This article reviews how rapid genome sequencing could revolutionize health care for acutely ill babies.
In a clinic on a side street in Kiev, the capital of Ukraine, doctors are doing something that, as far as is publicly known, is being done nowhere else in the world: using DNA from three different people to create babies for women who are infertile.
The Estonian government plans to provide free DNA-based lifestyle advice for 100,000 of its 1.3 million residents. It will be the first nation to provide a state-sponsored personal genetic information service – but some have warned that this might cause unnecessary worry for those who find out they have an elevated risk for certain diseases.
This article explores how children who survive congenital heart defects may face new problems as adults, and advocates for lifetime follow-up for all CCHD patients.
Mandatory screening of infants for critical congenital heart disease (CCHD) was linked with significantly decreased rates of related deaths, according to a new study.
Food and Drug Administration Commissioner Scott Gottlieb is questioning whether the law that encourages drugmakers to develop medicines for rare diseases is working the way it should.
Newborn screening is an effective public health intervention that not only decreases morbidity and mortality but is also cost-effective. State governments should move quickly to adopt screening programs for those conditions added to the RUSP and to prevent lags in adoption for future additions.
In this paper, we review the evolution of the field of public health genomics in the United States in the past two decades. Public health genomics focuses on effective and responsible translation of genomic science into population health benefits. We discuss the relationship of the field to the core public health functions and essential services, review its evidentiary foundation, and provide examples of current US public health priorities and applications. We cite examples of publications to illustrate how Genetics in Medicine reflected the evolution of the field. We also reflect on how public-health genomics is contributing to the emergence of “precision public health” with near-term opportunities offered by the US Precision Medicine (AllofUs) Initiative.